NASDAQ: NXGLNexgel Inc Stock Ownership - Who owns Nexgel?
Insider buying vs selling
Have Nexgel Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Scott Robert Henry | Director | 2025-04-10 | 3,000 | $2.61 | $7.82kSell |
| Adam R. Levy | Chief Executive Officer | 2025-04-01 | 4,000 | $3.01 | $12.04kSell |
| Scott Robert Henry | Director | 2025-03-10 | 3,000 | $2.87 | $8.62kSell |
| Adam R. Levy | Chief Executive Officer | 2025-03-03 | 4,000 | $3.16 | $12.64kSell |
| Scott Robert Henry | Director | 2025-02-10 | 3,000 | $3.27 | $9.80kSell |
| Adam R. Levy | Chief Executive Officer | 2025-02-03 | 4,000 | $3.64 | $14.56kSell |
| Scott Robert Henry | Director | 2025-01-07 | 3,000 | $3.37 | $10.10kSell |
| Adam R. Levy | Chief Executive Officer | 2025-01-02 | 4,000 | $3.96 | $15.83kSell |
| Scott Robert Henry | Director | 2024-12-20 | 3,000 | $4.65 | $13.93kSell |
| Jerome B. Zeldis | Director | 2024-11-20 | 3,636 | $2.75 | $10.00kBuy |
NXGL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NXGL insiders and whales buy or sell their stock.
NXGL Shareholders
What type of owners hold Nexgel Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Nachum Stein | 6.37% | 487,458 | $1.23M | Insider |
| John Nachum Stein | 6.16% | 471,456 | $1.19M | Insider |
| Adam R. Levy | 4.84% | 370,284 | $931.26k | Insider |
| David Stefansky | 2.99% | 228,663 | $575.09k | Insider |
| Renaissance Technologies LLC | 2.07% | 158,331 | $398.20k | Institution |
| Steven Mark Glassman | 2.05% | 156,655 | $393.99k | Insider |
| Scott Robert Henry | 1.76% | 135,053 | $339.66k | Insider |
| Jerome B. Zeldis | 1.39% | 106,664 | $268.26k | Insider |
| Adam E. Drapczuk Iii | 1.31% | 99,994 | $251.48k | Insider |
| Morgan Stanley | 1.15% | 87,804 | $220.83k | Institution |
NXGL vs Medical Stocks
Nexgel Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.